Chemotherapy-induced amenorrhea from adjuvant breast cancer treatment: The effect of the addition of taxanes

Clinical Breast Cancer

Volumn 6, Issue 5, 2005, Pages 421-424

  Davis, Amy L ^a   Klitus, Matthew ^a   Mintzer, David M ^a,b  

^a PENNSYLVANIA HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

Anthracyclines; Fertility; Menopause; Ovarian failure

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; PACLITAXEL; TAMOXIFEN; TAXANE DERIVATIVE;

ADULT; AGE; AMENORRHEA; BREAST CANCER; CANCER ADJUVANT THERAPY; CONTROLLED STUDY; DRUG INDUCED DISEASE; EARLY MENOPAUSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; PREMENOPAUSE; RETROSPECTIVE STUDY; REVIEW; STATISTICAL SIGNIFICANCE;

EID: 30544432123     PISSN: 15268209     EISSN: None     Source Type: Journal    
DOI: 10.3816/CBC.2005.n.046     Document Type: Article

References (12)

1. Shapiro CL, Recht A. Side effects of adjuvant treatment of breast cancer. N Eng J Med 2001; 344:1997-2008.
2. Reichman BS, Green KB. Breast cancer in young women: effect of chemotherapy on ovarian function, fertility, and birth defects. J Natl Caner Inst Monogr 1994; 16:125-129.
3. Bines J, Oleske DM, Cobleigh MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 1996; 14:1718-1729.
4. Goodwin PJ, Ennis M, Pritchard KI, et al. Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol 1999; 17:2365-2370.
5. Ganz P, Greendale GA, Peterson L, et al. Breast cancer in young women: reproductive and late health effects of treatment. J Clin Oncol 2003; 21:4184-4193.
6. Mintzer DM, Glassburn J, Mason BA, et al. Breast cancer in the very young patient: a multidisciplinary case presentation. Oncologist 2002; 7:547-554.
7. Collichio F, Pandya K. Amenorrhea following chemotherapy for breast cancer: effect on disease-free survival. Oncology (Huntington) 1994; 8:45-52.
8. Pagani O, O'Neill A, Castiglione M, et al. Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) trial VI. Eur J Cancer 1998; 34:632-640.
9. Brinker H, Rose C, Rank F, et al. Evidence of a castration-mediated effect of adjuvant cytotoxic chemotherapy in pre-menopausal breast cancer. J Clin Oncol 1987; 5:1771-1778.
10. Bianco AR, Del Mastro L, Gallo C, et al. Prognostic role of amenorrhea induced by adjuvant chemotherapy in pre-menopausal patients with early breast cancer. Br J Cancer 1991; 63:799-803.
11. Nabholtz JM, Pienkowski T, Mackey J, et al. Phase III trial comparing TAC (docetaxel, doxorubicin, cyclophosphamide) with FAC (5FU, doxorubicin, cyclophosphamide) in the adjuvant treatment of node positive breast cancer (BC) patients: interim analysis of the BCIRG 001 study. Proc Am Soc Clin Oncol 2002; 21:35a (Abstract #141).
12. Partridge AH, Gelber S, Peppercorn J, et al. Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol 2004; 22:4174-4182.